High-dose furmonertinib combined with bevacizumab and pemetrexed in non-small cell lung cancer patients with

Authors: Qi Zhao, Haiyang Chen, Lili Wang, Yingxi Wu, Yufeng Wu, Shuxiang Ma, Sen Yang, Zhen He, Peng Li, Qiming Wang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.8609

Source: Full article

---

Abstract

8609